Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: The S100B/RAGE pathway

Journal of Proteomics

Volumn 75, Issue 15, 2012, Pages 4758-4765

  Montaner, Joan ^a   Mendioroz, Maite ^a   Delgado, Pilar ^a   García Berrocoso, Teresa ^a   Giralt, Dolors ^a   Merino, Cristina ^a   Ribó, Marc ^a   Rosell, Anna ^a   Penalba, Anna ^a   Fernández Cadenas, Israel ^a   Romero, Francisco ^a   Molina, Carlos ^a   Alvarez Sabín, Jose ^a   Hernández Guillamon, Mar ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Hemorrhagic; Ischemic; S100B; SRAGE; Stroke

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CASPASE 3; CHIMERIN; D DIMER; GELATINASE B; NEUROPEPTIDE Y; NEUROTROPHIN 3; PROTEIN S100B;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; STROKE; TIME FACTORS;

EID: 84864093291     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.01.033     Document Type: Article

References (23)

1. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2010 update: a report from the American heart association. Circulation 2010, 121:e46-e215.
2. Rosamond W.D., Folsom A.R., Chambless L.E., Wang C.H., McGovern P.G., Howard G., et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerotic Risk in Communities (ARIC) cohort. Stroke 1999, 30:736-743.
3. Anderson C.S., Huang Y., Arima H., Heeley E., Skulina C., Parsons M.W., et al. INTERACT Investigators. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke 2010, 41:307-312.
4. Rasool A.H., Rahman A.R., Choudhury S.R., Singh R.B. Blood pressure in acute intracerebral haemorrhage. J Hum Hypertens 2004, 18:187-192.
5. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) investigators Antihypertensive Treatment of Acute Cerebral Hemorrhage. Crit Care Med 2010, 38:637-648.
6. Oliveira-Filho J., Silva S.C., Trabuco C.C., Pedreira B.B., Sousa E.U., Bacellar A. Detrimental effect of blood pressure reduction in the first 24h of acute stroke onset. Neurology 2003, 61:1047-1051.
7. Vlcek M., Schillinger M., Lang W., Lalouschek W., Bur A., Hirschl M.M. Association between course of blood pressure within the first 24h and functional recovery after acute ischemic stroke. Ann Emerg Med 2003, 42:619-626.
8. Aygun N., Masaryk T.J. Diagnostic imaging for intracerebral hemorrhage. Neurosurg Clin N Am 2002, 13:313-334.
9. Montaner J., Perea-Gainza M., Delgado P., Ribó M., Chacón P., Rosell A., et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 2008, 39:2280-2287.
10. Muller R., Möckel M. Logistic regression and CART in the analysis of multimarker studies. Clin Chim Acta 2008, 394:1-6.
11. Allard L., Lescuyer P., Burgess J., Leung K.Y., Ward M., Walter N., et al. ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. Proteomics 2004, 4:2242-2251.
12. Foerch C., Curdt I., Yan B., Dvorak F., Hermans M., Berkefeld J., et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry 2006, 77:181-184.
13. Bloomfield S.M., McKinney J., Smith L., Brisman J. Reliability of S100B in predicting severity of central nervous system injury. Neurocrit Care 2007, 6:121-138.
14. Foerch C., Singer O.C., Neumann-Haefelin T., du Mesnil de Rochemont R., Stenimetz H., Sitzer M. Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol 2005, 62:1130-1134.
15. Savola O., Pyhtinen J., Leino T.K., Siitonen S., Niemela O., Hillborn M. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma 2004, 56:1229-1234.
16. Butter T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 1997;28:1961-5.
17. Delgado P., Alvarez Sabin J., Santamarina E., Molina C.A., Quintana M., Rosell A., et al. Plasma S100B level after acute spontaneous intracerebral hemorrhage. Stroke 2006, 37:2837-2839.
18. Yan S.F., Naka Y., Hudson B.I., Herold K., Yan S.D., Ramasamy R., et al. The ligand/SRAGE axis: lighting the fuse and igniting vascular stress. Curr Atheroscler Rep 2006, 8:232-239.
19. Chang J.S., Wendt T., Qu W., Kong L., Zou Y.S., Schmidt A.M., et al. Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products. Circ Res 2008, 102:905-913.
20. Park I.H., Yeon S.I., Ypun J.H., Choi J.E., Sasaki N., Choi I.H., et al. Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Mol Immunol 2004, 40:1203-1211.
21. Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 2007, 7:711-724.
22. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1999, 1450:191-231.
23. Efstathiou S.P., Tsioulos D.I., Zacharos I.D., Tsiakou A.G., Mitromaras A.G., Mastorantonakis S.E., et al. A new classification tool for clinical differentiation between haemorrhagic and ischaemic stroke. J Intern Med 2002, 252:121-129.